Credit Suisse lifts Solid Biosciences [SLDB] rating to Neutral and price target to $7

CEI Stock

Credit Suisse took its Solid Biosciences [SLDB] rating to the equivalent of Neutral from Underperform, and the price target to $7.0, in a research note dated 2021-01-08. That figure represents around a -17.45% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with SVB Leerink’s analysts downgrading the shares […]